Chapter 4: Regulations Flashcards
Addiction
a substance that encourages dependence on it
Chemical name
drug name that reflects the chemical makeup of the drug
Clinical trials
scientific tests that research the efficacy and safety of a medication
Compassionate use
the use of an investigational new drug (IND) in patients who are suffering greatly and may die without the drug
Control group
group of people in clinical trials who receive the placebo or usual treatment, in contrast to the group given the treatment or medication being studied
Controlled Substances
Act
substances monitored under the Comprehensive Drug Abuse Prevention and Control Act, a law enacted in 1971 to control the distribution and use of all depressant and stimulant drugs and other drugs of abuse or potential abuse as may be designated by the Drug Enforcement Administration of the Department of Justice
Double-blind
neither the patient nor the researcher in the clinical trial knows who has the placebo and who has the drug being tested
DEA
Drug Enforcement Agency of the Department of Justice
FDA
Food and Drug Administration
Generic name
official name of the drug; nonproprietary
IND
Investigational New Drug
NDA
New drug application
OSHA
Occupational Safety and Health Administration
Patent medicine
remedy of questionable value that may harm the patient
Placebo
inactive substance given to satisfy a patient’s demand for medicine; a drug or treatment used as a nonspecific or inactive control in a test of a therapy that is suspected of being useful for a particular disease or condition
Substance abuse
misuse or improper use of medications
Mr. Dupee is upset that he is unable to obtain a drug in the United States. He knows of a website on which he can order the medication from Mexico. What are the potential dangers of ordering a drug from another country? How would you discuss this with him?
The drugs ordered from another country may not be the same as those in America. They are not con- trolled by the FDA. Discuss safety concerns with the patient. Help him access resources if money is an issue.
Not all people who volunteer for clinical trials are acceptable for the research. What do you think could disqualify a patient from participating in clinical trials?
The volunteer may have a comorbid condition that excludes participation. Sometimes the researchers are also looking for a mixture of genders, races, and ages, which might eliminate this volunteer. Also, illness, pregnancy, distance from research facility, and lack of interest in participating could impede the trials.